MERK.JK实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 10:43):

Stats
今日成交量	3 800.00
平均成交量	55 596.00
市值	1 827.84B
EPS	IDR87.11 ( 2023-09-30 )
下一个收益日期	( IDR0 ) 2024-05-29
Last Dividend	IDR0 ( N/A )
Next Dividend	IDR0 ( N/A )
P/E	10.25
ATR14	IDR8.75 (0.21%)

PT Merck Tbk 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

PT Merck Tbk 财务报表

Annual	2023
营收:	IDR961.43B
毛利润:	IDR391.73B (40.74 %)
EPS:	IDR397.86

FY	2023
营收:	IDR961.43B
毛利润:	IDR391.73B (40.74 %)
EPS:	IDR397.86

FY	2022
营收:	IDR1 124.60B
毛利润:	IDR427.59B (38.02 %)
EPS:	IDR401.42

FY	2021
营收:	IDR1 064.39B
毛利润:	IDR398.68B (37.46 %)
EPS:	IDR293.89

Financial Reports:

No articles found.

PT Merck Tbk

PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. It operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in discovering, developing, manufacturing, and marketing pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders comprising hyperthyroidism and hypothyroidism. In addition, it leases and manages properties. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. PT Merck Tbk is a subsidiary of Merck Holding GmbH.